ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses

Autor: Matthew L. Albert, Zia Khan, Margaret Solon, Trinna L. Cuellar, Timothy W. Behrens, Anna-Maria Herzner, Benjamin Haley, László G. Kömüves, Eric L. Van Nostrand, Gene W. Yeo, Ronald Chen, Zora Modrusan, Sara Chan, Ximo Pechuan-Jorge
Rok vydání: 2020
Předmět:
Zdroj: The Journal of Experimental Medicine
ISSN: 1540-9538
Popis: hnRNPC prevents release of inverted-repeat Alu double-stranded RNA into the cytosol by masking cryptic splice sites. Herzner et al. found that deficiency in hnRNPC led to dysregulation of splicing and increased abundance of intronic double-stranded RNA, which together with ADAR deficiency resulted in a synergistic increase in spontaneous MDA5-dependent IFN responses.
Cytosolic double-stranded RNA (dsRNA) initiates type I IFN responses. Endogenous retroelements, notably Alu elements, constitute a source of dsRNA. Adenosine-to-inosine (A-to-I) editing by ADAR induces mismatches in dsRNA and prevents recognition by MDA5 and autoinflammation. To identify additional endogenous dsRNA checkpoints, we conducted a candidate screen in THP-1 monocytes and found that hnRNPC and ADAR deficiency resulted in synergistic induction of MDA5-dependent IFN responses. RNA-seq analysis demonstrated dysregulation of Alu-containing introns in hnRNPC-deficient cells via utilization of unmasked cryptic splice sites, including introns containing ADAR-dependent A-to-I editing clusters. These putative MDA5 ligands showed reduced editing in the absence of ADAR, providing a plausible mechanism for the combined effects of hnRNPC and ADAR. This study contributes to our understanding of the control of repetitive element–induced autoinflammation and suggests that patients with hnRNPC-mutated tumors might maximally benefit from ADAR inhibition-based immunotherapy.
Graphical Abstract
Databáze: OpenAIRE